U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
184741184741Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based RegimenCompletedNo Results AvailableHIV InfectionsDrug: Videx EC|Drug: Epivir|Drug: Sustivahttps://ClinicalTrials.gov/show/NCT00135382
184742184742Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily RegimenCompletedNo Results AvailableHIV InfectionsDrug: stavudine extended-release, lamivudine, efavirenzhttps://ClinicalTrials.gov/show/NCT00135369
184743184743Study of Reyataz in HIV-infected Patients With Lipodystrophy SyndromeCompletedHas ResultsHIV-Associated Lipodystrophy SyndromeDrug: Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs)|Drug: continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs)https://ClinicalTrials.gov/show/NCT00135356
184744184744A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing RegimenCompletedNo Results AvailableHIV InfectionsDrug: Atazanvir/ritonavir + efavirenz|Drug: Atazanvir/ritonavir + efavirenzhttps://ClinicalTrials.gov/show/NCT00135343
184745184745An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes MellitusCompletedHas ResultsDiabetes Mellitus, Type 2Drug: exenatide|Drug: rosiglitazonehttps://ClinicalTrials.gov/show/NCT00135330
184746184746AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid MalignanciesCompletedNo Results AvailableCancerDrug: darbepoetin alfahttps://ClinicalTrials.gov/show/NCT00135317
184747184747ACHIEVE: Optimizing the Treatment of Secondary HyperparathyroidismCompletedNo Results AvailableSecondary HyperparathyroidismDrug: Sensipar®|Drug: Vitamin Dhttps://ClinicalTrials.gov/show/NCT00135304
184748184748Effect of Leukoreduced Blood Transfusions on Infection Following TraumaCompletedNo Results AvailableWounds and InjuriesProcedure: Leukoreduced blood transfusionhttps://ClinicalTrials.gov/show/NCT00135291
184749184749Cerebrospinal Fluid (CSF) Drainage and Cytokine Profiling in the Treatment of Acute Spinal Cord Injury (SCI)RecruitingNo Results AvailableSpinal Cord InjuriesProcedure: CSF will be drained using an epidural catheter inserted via lumbar puncture for 72 hours.https://ClinicalTrials.gov/show/NCT00135278
184750184750PROS Smokebusters: Adolescent Smoking Cessation in Pediatric Primary CareCompletedNo Results AvailableHealth Care Quality, Access, and Evaluation|Smoking CessationBehavioral: smoking cessation, practice changehttps://ClinicalTrials.gov/show/NCT00135265
184751184751Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2TerminatedNo Results AvailableLung Diseases, ObstructiveProcedure: nasal cannula oxygen delivery|Procedure: supplemental oxygen delivery by hoodhttps://ClinicalTrials.gov/show/NCT00135252
184752184752Study Care Versus Usual Care for Acute Mechanical Lower Back PainCompletedNo Results AvailableLow Back Pain, MechanicalProcedure: Study care|Procedure: Usual carehttps://ClinicalTrials.gov/show/NCT00135239
184753184753ASCEND: A Study of Cardiovascular Events iN DiabetesActive, not recruitingNo Results AvailableDiabetes MellitusDrug: aspirin|Drug: Omega-3-acid Ethyl Esters|Drug: Placebo Aspirin|Drug: Placebo omega-3-Ethyl Estershttps://ClinicalTrials.gov/show/NCT00135226
184754184754PROS Brief Smoking Cessation Counseling in Pediatric Practice to Reduce Secondhand Smoke Exposure of Young ChildrenCompletedNo Results AvailableHealth Care Quality, Access, and Evaluation|Smoking CessationBehavioral: training in smoking cessationhttps://ClinicalTrials.gov/show/NCT00135213
184755184755Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple MyelomaActive, not recruitingHas ResultsMultiple MyelomaDrug: Iodine I 131 Tositumomabhttps://ClinicalTrials.gov/show/NCT00135200
184756184756Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple MyelomaCompletedNo Results AvailableMultiple MyelomaDrug: VELCADE|Drug: Doxil|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00135187
184757184757Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The Followpace StudyActive, not recruitingNo Results AvailableArrhythmia|Heart Diseaseshttps://ClinicalTrials.gov/show/NCT00135174
184758184758Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck CancerActive, not recruitingNo Results AvailableHead and Neck NeoplasmsProcedure: FDG-PET-based dose escalation using intensity modulated radiation therapy (IMRT).https://ClinicalTrials.gov/show/NCT00135161
184759184759Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control GroupCompletedNo Results AvailableTranssexualismProcedure: Filling out a questionnaire on libido and possible partner relationship|Procedure: Sex steroid analysishttps://ClinicalTrials.gov/show/NCT00135148
184760184760Therapy for Children With NeuroblastomaCompletedNo Results AvailableNeuroblastomaDrug: Gefitinib, Irinotecan, Cycophosphamide, Doxorubicin, Etoposide, Cisplatin, Topotecan, Carboplatin, Melphalan, 13-cis retinoic acid|Procedure: Radiation therapy, Surgery, Peripheral Stem cell transplanthttps://ClinicalTrials.gov/show/NCT00135135
184761184761Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse HeadacheCompletedNo Results AvailableHeadacheDrug: prednisolonehttps://ClinicalTrials.gov/show/NCT00135122
184762184762Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic NeuropathyCompletedNo Results AvailableDiabetic NeuropathiesDrug: SPM 927https://ClinicalTrials.gov/show/NCT00135109
184763184763Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal InsulinCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: insulin glulisine|Drug: insulin glarginehttps://ClinicalTrials.gov/show/NCT00135096
184764184764Variable Bolus Regimen 1-2-3 for Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: insulin glulisinehttps://ClinicalTrials.gov/show/NCT00135083
184765184765Hospital In-Patient Insulin StudyTerminatedNo Results AvailableDiabetes Mellitus, Type 2Drug: Detemirhttps://ClinicalTrials.gov/show/NCT00135070
184766184766Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal InsulinCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: insulin glulisine|Drug: insulin glarginehttps://ClinicalTrials.gov/show/NCT00135057
184767184767A Trial of Taurine Supplementation in Parenteral Nutrition 1RecruitingNo Results AvailableCholestasisProcedure: intravenous taurine in nutritional supplementhttps://ClinicalTrials.gov/show/NCT00135044
184768184768Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel SyndromeCompletedNo Results AvailableIrritable Bowel SyndromeDrug: Bifidobacterium infantis 35624https://ClinicalTrials.gov/show/NCT00135031
184769184769Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast CancerCompletedNo Results AvailableBreast CancerDrug: celecoxib and chemotherapyhttps://ClinicalTrials.gov/show/NCT00135018
184770184770Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)CompletedNo Results AvailableGastrointestinal Stromal TumorsDrug: AMN107, STI571https://ClinicalTrials.gov/show/NCT00135005

* Görseller ve İçerik tekif hakkına sahip olabilir